A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1

NCT01373606 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatorenal Syndrome Type 1

Interventions

DRUG: Terlipressin

Sponsor

Ferring Pharmaceuticals